October 16, 2017
The new criteria elevate the importance of REM sleep disorder and incorporate the biomarker MIBG. DLB Consortium leaders hope that the diagnostic and management guidelines help clinicians catch more DLB cases. This resource will make this cognition and movement disorder more tractable for biomarker research, longitudinal cohorts, and clinical trials. Have you adopted the guidelines? What’s working, what’s not? How are they informing your research? View here.